Facilities

Fujifilm aims to become a ‘total healthcare company’, acquires Biogen facility

07-Aug-2019 By Maggie Lynch

Fujifilm completed the acquisition of Biogen manufacturing site in Denmark for $890m in a cash transaction as it works to expand its global business lines.

Celltrion sets up Chinese JV and eyes manufacturing facility in country

30-Jul-2019 By Ben Hargreaves

Celltrion has partnered with Nan Fung Group to create Vcell Healthcare, which will manufacture and commercialize three of Celltrion’s biosimilar products in China.

July roundup sees flurry of partnership deals

29-Jul-2019 By Ben Hargreaves

The summer months are traditionally slow on movements across the industry, but July saw a number of manufacturing partnership deals take place as companies look ahead to product commercialization.

Lonza readies for ‘new wave of ADC therapies’ with Visp expansion

25-Jul-2019 By Ben Hargreaves

Lonza already manufacturers three out of five commercially available ADCs but is preparing for additional demand with a two-year expansion project at its Visp site.

Bioscience incubator to be built in Illinois to support growing Midwest hub

25-Jul-2019 By Maggie Lynch

Rosalind Franklin University of Medicine and Science opens its incubator, Helix 51, creating wet lab and research space for the Illinois bioscience hub.

UK cell and gene manufacturing employment increases by 30%

19-Jul-2019 By Ben Hargreaves

CGT Catapult reports that employment has increased substantially, and production capacity has grown by 60% in the UK cell and gene therapy manufacturing industry.

WHP completes ADC Bio’s £5m cleanroom in UK site

18-Jul-2019 By Vassia Barba

WHP completes the building of a cleanroom facility at a site expected to deliver ‘the next generation of anticancer blockbuster ADC drugs’.

Kite builds own viral vector supply through facility construction

17-Jul-2019 By Ben Hargreaves

Kite will bolster its supply of vectors by adding a facility to its existing site in California to be used in cell therapy production.

Paragon’s Maryland facility adds Passage Bio’s manufacturing suite

11-Jul-2019 By Maggie Lynch

Paragon and Passage Bio enter a collaboration agreement to develop a dedicated manufacturing suite at the former’s Maryland facility, as the latter’s gene therapy candidates enter the clinic.

Grifols expands in Africa with manufacturing facility

11-Jul-2019 By Vassia Barba

Grifols builds its first plant in Northern Africa for Morocco-based Soludia Maghreb, which will be used in the production of intravenous solutions bags.

BioNTech aims to advance pipeline to the clinic with $325m investment

10-Jul-2019 By Maggie Lynch

BioNTech completed a $325m Series B financing rounds as the biotech looks to advance its therapeutics pipeline and manufacturing capabilities.

FDA issues Biocon Form 483 with 12 observations

09-Jul-2019 By Vassia Barba

Following a pre-approval inspection of Biocon’s facilities in Malaysia, the US FDA issues 12 observations through a Form 483.

Novel manufacturing technologies ‘fit poorly’ into regulatory models, says EMA

05-Jul-2019 By Ben Hargreaves

The EMA looks to the future by posting its five key priorities to address in the coming five years, which includes the need to recruit expertise in ‘novel manufacturing technologies’.

Five deals reshaping the CDMO industry this year

05-Jul-2019 By Ben Hargreaves

The major trend so far in 2019 is the willingness to deploy capital to expand services in the cell and gene therapy sector, and we outline the five most significant deals thus far.

Fujifilm plots third cell culture facility in Netherlands

02-Jul-2019 By Ben Hargreaves

Fujifilm announces plans to open its third manufacturing facility for cell culture media, joining existing facilities in the US and Japan.